Evidence map›Paper›PMID 16436701›Full record

ArticleAntimicrobial agents and chemotherapy2006

Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions.

Tali Rydlo, Shahar Rotem, Amram Mor

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Application of immobilized synthetic anti-lipopolysaccharide peptides for the isolation and detection of bacteria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  9. Article
  10. Boosting salt resistance of short antimicrobial peptides.Antimicrobial agents and chemotherapy · 2013
    Article
  11. Article
  12. Article
  13. Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tali RydloDepartment of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel.
Shahar Rotem
Amram Mor

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial properties of the frog-derived peptide dermaseptin S4 and a series of synthetic derivatives against the food pathogen Escherichia coli O157:H7 were investigated under extreme incubation conditions. The 28-mer analog K4K20S4 (P28) displayed an MIC of 8 microM and rapid bactericidal kinetics under standard culture conditions. Potent bactericidal properties were maintained at high salt concentrations, under acidic or basic conditions, and at extreme temperatures. The N-terminal 14-mer sequence (P14) displayed higher potency (MIC, 4 microM) but only within a narrow range of incubation conditions, pointing to the importance of the C-terminal domain of P28. The potency range was reextended upon conjugation of aminododecanoic acid to P14. The resulting lipopeptide was even more potent (MIC, 2 microM) and affected bacterial viability under most of the conditions tested, including in commercial apple juice. The mechanistic implications of peptides' hydrophobicity, charge, structure, and binding to an idealized membrane were probed and are discussed here. Collectively, the data indicate interest in simple peptide-based compounds for design of antimicrobials that affect pathogens under a variable range of incubation conditions.

Indexed as

Amino Acid SequenceAmphibian ProteinsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesEscherichia coli O157Hydrogen-Ion ConcentrationMicrobial Sensitivity TestsMolecular Sequence DataProtein Structure, SecondaryStructure-Activity RelationshipAmphibian ProteinsAnti-Bacterial AgentsAntimicrobial Cationic Peptidesdermaseptin 4 protein, Phyllomedusa

Identifiers

PMID16436701
PMCPMC1366882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.